Lubiprostone
Back to searchMolecule Structure
Scientific Name
Lubiprostone
Description of the Drug
Lubiprostone is a prostaglandin derivative used to treat constipation caused by irritable bowel syndrome and opioid-use.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01046
http://www.drugbank.ca/drugs/DB01046
Brand Name(s)
Amitiza
Company Owner(s)
Teva Pharmaceuticals Usa Inc, Sucampo Pharma Americas Llc, Anchen Pharmaceuticals Inc, Dr Reddys Laboratories Ltd, Amneal Pharmaceuticals Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Chloride channel protein 2 | SINGLE PROTEIN | OPENER | CHEMBL1628478 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL217184 | |
DrugBank | DB01046 | |
PubChem: Thomson Pharma | 16257021 | 14780722 |
PubChem | 157920 | |
Nikkaji | J2.581.749D | |
EPA CompTox Dashboard | DTXSID5048639 | |
DrugCentral | 4123 | |
Brenda | 75871 | |
ChemicalBook | CB4855611 | CB32129504 |
Guide to Pharmacology | 4242 | |
rxnorm | LUBIPROSTONE | AMITIZA |
PubChem: Drugs of the Future | 12015646 | |
ZINC | ZINC000004217732 |